(Q48636687)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165363%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Comparing treatments of alcoholism on craving and biochemical measures of alcohol consumptionst (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165363%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165363%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Stefania Premi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165363%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Ezio Manzato

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165363%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Alfio Lucchini

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165363%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165363%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychoactive Drugs

23 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165363%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165363%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165363%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

211-217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165363%20AND%20SRC:MED&resulttype=core&format=json

Dilinoleoylphosphatidylcholine decreases ethanol-induced cytochrome P4502E1.

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Advances in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Methionine synthase. a possible prime site of the ethanolic lesion in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

A risk-benefit assessment of naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Safety issues concerning the use of disulfiram in treating alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Traditional markers of excessive alcohol use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

S-Adenosyl-L-methionine and mitochondrial reduced glutathione depletion in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Different actions ofγ-hydroxybutyrate: A critical outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Alcoholic liver injury: pathogenesis and therapy in 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Alcoholic liver disease: new insights in pathogenesis lead to new treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Prevention and treatment of liver fibrosis based on pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Medical Disorders of Alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Gammahydroxybutyrate: an endogenous regulator of energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Pharmacotherapy of alcohol dependence: a review of the clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Assessing the efficacy of medical treatments for alcohol use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Immunization against intestinal bacterial endotoxin prevents alcoholic fatty liver in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Effect of late treatment with gamma-hydroxybutyrate on the histological and behavioral consequences of transient brain ischemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Alcohol and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Recent Advances in Alcoholic Liver Disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Biochemical detection and monitoring of alcohol abuse and abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Review article: current management of alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Effect of gamma-hydroxybutyric acid on lipid peroxidation and tissue lactate level in experimental head trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Effect of gamma-hydroxybutyric acid on tissue Na+,K- ATPase levels after experimental head trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2006.10399846

10.1080/02791072.2006.10399846

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17165363%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference